Literature DB >> 9919675

Transduction of multiple drug resistance of Salmonella enterica serovar typhimurium DT104.

H Schmieger1, P Schicklmaier.   

Abstract

Epidemic strain Salmonella typhimurium DT104 is characterized by various multiresistance patterns. At least some of the resistance genes are organized as integrons. Resistance genes of DT104 isolates can be efficiently transduced by P22-like phage ES18 and by phage PDT17 which is released by all DT104 isolates so far analyzed. Cotransduction tests demonstrate that the resistance genes, although not organized in a unique integron, are tightly clustered on the Salmonella chromosome. The spread of resistance genes in this strain by generalized transduction is discussed.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9919675     DOI： 10.1111/j.1574-6968.1999.tb13381.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN： 0378-1097            Impact factor:   2.742


  53 in total

1.  Molecular characterization of Irish Salmonella enterica serotype typhimurium: detection of class I integrons and assessment of genetic relationships by DNA amplification fingerprinting.

Authors:  M Daly; J Buckley; E Power; C O'Hare; M Cormican; B Cryan; P G Wall; S Fanning
Journal:  Appl Environ Microbiol       Date:  2000-02       Impact factor: 4.792

2.  Prophage contribution to bacterial population dynamics.

Authors:  Lionello Bossi; Juan A Fuentes; Guido Mora; Nara Figueroa-Bossi
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

Review 3.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

4.  Molecular characterization of a prophage of Salmonella enterica serotype Typhimurium DT104.

Authors:  Kiyoshi Tanaka; Kei Nishimori; Sou-Ichi Makino; Tomoko Nishimori; Toru Kanno; Ryoko Ishihara; Toshiya Sameshima; Masato Akiba; Muneo Nakazawa; Yuichi Yokomizo; Ikuo Uchida
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  From phenotype to genotype: a Bayesian solution.

Authors:  M J Denwood; A E Mather; D T Haydon; L Matthews; D J Mellor; S W J Reid
Journal:  Proc Biol Sci       Date:  2010-10-27       Impact factor: 5.349

6.  Identification of novel Salmonella enterica serovar Typhimurium DT104-specific prophage and nonprophage chromosomal sequences among serovar Typhimurium isolates by genomic subtractive hybridization.

Authors:  Armand P H M Hermans; Tjakko Abee; Marcel H Zwietering; Henk J M Aarts
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

7.  The genomic island SGI1, containing the multiple antibiotic resistance region of Salmonella enterica serovar Typhimurium DT104 or variants of it, is widely distributed in other S. enterica serovars.

Authors:  Renee S Levings; Diane Lightfoot; Sally R Partridge; Ruth M Hall; Steven P Djordjevic
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

8.  Worldwide prevalence of class 2 integrases outside the clinical setting is associated with human impact.

Authors:  Carlos M Rodríguez-Minguela; Juha H A Apajalahti; Benli Chai; James R Cole; James M Tiedje
Journal:  Appl Environ Microbiol       Date:  2009-06-05       Impact factor: 4.792

9.  Bacteriophages Isolated from Chicken Meat and the Horizontal Transfer of Antimicrobial Resistance Genes.

Authors:  Amira Shousha; Nattakarn Awaiwanont; Dmitrij Sofka; Frans J M Smulders; Peter Paulsen; Michael P Szostak; Tom Humphrey; Friederike Hilbert
Journal:  Appl Environ Microbiol       Date:  2015-05-01       Impact factor: 4.792

10.  Acquisition of resistance to extended-spectrum cephalosporins by Salmonella enterica subsp. enterica serovar Newport and Escherichia coli in the turkey poult intestinal tract.

Authors:  C Poppe; L C Martin; C L Gyles; R Reid-Smith; P Boerlin; S A McEwen; J F Prescott; K R Forward
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.